Drug: MELPHALAN Injury: Upper respiratory tract infection Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
118927055 | MELPHALAN | Upper respiratory tract infection | TAKEDA | 67.00 YR | F | 94 KG | 20160810 | GB |
119525234 | MELPHALAN | Upper respiratory tract infection | TEVA | 67.00 YR | F | 94 KG | 20160902 | GB |
119808454 | MELPHALAN | Upper respiratory tract infection | BAUSCH AND LOMB | 67.00 YR | F | 94 KG | 20160901 | GB |
121204963 | MELPHALAN | Upper respiratory tract infection | TAKEDA | 74.47 YR | F | 50 KG | 20160811 | JP |
123253046 | MELPHALAN | Upper respiratory tract infection | TAKEDA | 87.00 YR | M | 82 KG | 20160819 | GB |
125182584 | MELPHALAN | Upper respiratory tract infection | CONCORDIA | 67.00 YR | F | 94 KG | 20160906 | GB |
1227378111 | MELPHALAN | Upper respiratory tract infection | TAKEDA | 77.00 YR | F | 87 KG | 20160819 | PL |
Total Records: 7 Number of Pages: 1